KPKrisanee Pansue

Krisanee Pansue

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Krisanee Pansue has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Juliet Ryan

    MD Program, Weill Cornell Medical College, New York, NY, USA

    1 shared publication
  • Juthamanee Moonwong

    Center of Excellence for Pediatric Infectious Diseases and Vaccines, Chulalongkorn University, Bangkok, Thailand

    1 shared publication
  • Kessarin Thanapirom

    Division of Gastroenterology and Hepatology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

    1 shared publication
  • Pathariya Promsena

    Center of Excellence for Pediatric Infectious Diseases and Vaccines, Chulalongkorn University, Bangkok, Thailand

    1 shared publication
  • Surinda Kawichai

    Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand

    1 shared publication
  • Thanyawee Puthanakit

    Department of Pediatrics, Division of Infectious Disease, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

    1 shared publication

Latest Publications

  • High prevalence of hepatitis C virus infection among adolescents and young adults attending HIV and sexual health clinics

    by Krisanee Pansue, Pathariya Promsena, Wipaporn Natalie Songtaweesin, Juthamanee Moonwong, Juliet Ryan, Surinda Kawichai, Kessarin Thanapirom, Thanyawee Puthanakit

    Background: The prevalence of hepatitis C virus (HCV) infection among Thai adults is 0.5%–1.0%. This study aims to determine the prevalence of HCV infection among adolescents and young adults (AYA) accessing HIV/sexual health clinics. Methods: A cross-sectional study was conducted among AYA aged 15–24 years attending HIV/sexual health clinics in Bangkok, Thailand. The HCV infection prevalence, defined by anti-HCV antibody positivity using rapid diagnostic tests (SD BIOSENSOR, Korea), were reported with proportions and a 95% confidence interval (CI). Multivariate logistic regression was performed to identify factors associated with HCV infection. Results: From March to August 2023, 300 AYAs with a median age of 21 (interquartile range 20–23) years were enrolled into the study. One-third (29.7%) were people living with HIV (PLHIV). The overall prevalence of HCV infection was 2.7% (95%CI 1.2–5.2). Prevalence was higher among PLHIV (5.6%) compared to AYA without HIV (1.4%) ( p -value 0.053). The factor most significantly associated with HCV infection was people who used drugs (adjusted odds ratio 15.3, 95% CI 2.9–82.0, p -value 0.001). Conclusions: History of drug use was associated with the highest HCV infection prevalence. PLHIV had a trend of higher prevalence. HCV screening in HIV/sexual health clinics is recommended for early detection, treatment, and transmission reduction.